These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 29267597

  • 1. Low bone mineral density among HIV-infected patients in Brazil.
    Chaba DCDS, Soares LR, Pereira RMR, Rutherford GW, Assone T, Takayama L, Fonseca LAM, Duarte AJS, Casseb J.
    Rev Inst Med Trop Sao Paulo; 2017 Dec 21; 59():e89. PubMed ID: 29267597
    [Abstract] [Full Text] [Related]

  • 2. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
    Pinto Neto LF, Ragi-Eis S, Vieira NF, Soprani M, Neves MB, Ribeiro-Rodrigues R, Miranda AE.
    J Clin Densitom; 2011 Dec 21; 14(4):434-9. PubMed ID: 22051092
    [Abstract] [Full Text] [Related]

  • 3. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 4. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar 30; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 5. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    Bregigeon S, Galinier A, Zaegel-Faucher O, Cano CE, Obry V, Laroche H, Trijau S, Saout A, Poizot-Martin I.
    AIDS; 2017 Jul 17; 31(11):1573-1577. PubMed ID: 28426535
    [Abstract] [Full Text] [Related]

  • 6. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
    Escota GV, Mondy K, Bush T, Conley L, Brooks JT, Önen N, Patel P, Kojic EM, Henry K, Hammer J, Wood KC, Lichtenstein KA, Overton ET.
    AIDS Res Hum Retroviruses; 2016 Jan 17; 32(1):59-67. PubMed ID: 26366785
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Jan 17; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

  • 8. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.
    Neth J Med; 2017 May 17; 75(4):138-144. PubMed ID: 28522769
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lachâtre M, Choisy P, Ajana F, Bourdic K, Viget N, Riff B, Quertainmont Y, Cortet B, Boufassa F, Chéret A.
    AIDS; 2018 Nov 28; 32(18):2689-2696. PubMed ID: 30234605
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, Sheng WH, Sun HY, Shih TT.
    J Microbiol Immunol Infect; 2014 Apr 01; 47(2):109-15. PubMed ID: 23073318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T, Bone-D Study Group.
    HIV Med; 2017 Apr 01; 18(4):235-244. PubMed ID: 27477214
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J, Viget N, Drumez E, Cortet B, Robineau O.
    Med Mal Infect; 2018 Oct 01; 48(7):442-448. PubMed ID: 29699830
    [Abstract] [Full Text] [Related]

  • 20. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA.
    HIV Clin Trials; 2003 Oct 01; 4(5):337-46. PubMed ID: 14583850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.